{'fraction_non_alphanumeric': 0.023758099352051837, 'fraction_numerical': 0.01079913606911447, 'mean_word_length': 5.025974025974026, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A new era in lung cancer care: from early diagnosis to personalized treatment

Lung cancer remains one of the major burdens worldwide: for 2019 has been estimated, for both sexes, as the first case of death among others cancer type and the second for new diagnosis (1). Moreover, the newly diagnosis will be performed in patients with advanced disease, locally advanced or metastatic disease, with less therapeutic efficacy options and reduced chance of survival.